Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cephac Europe was a prominent French Contract Research Organization (CRO) specializing in bioanalysis, pharmacokinetics, and drug metabolism studies. Founded as the Centre d'Etudes de Pharmacocinétique et de Chimie, the company provided essential support for pharmaceutical development through its expertise in analytical chemistry and clinical pharmacology. It operated a major facility in Saint-Benoît, France, serving a global client base of pharmaceutical and biotechnology companies. In 1998, Cephac was acquired by MDS Pharma Services, becoming a key component of their European bioanalytical operations. Following subsequent industry consolidations, its legacy and facilities were eventually integrated into Eurofins Scientific. The company was recognized for its early adoption of Good Laboratory Practice (GLP) standards in Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cephac Europe.